These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8796625)

  • 1. Chronic cisplatin nephropathy, contrast media, and creatinine.
    Thomsen HS; Dorph S; Larsen S; Horn T; Hemmingsen L; Skaarup P; Golman K; Svendsen O
    Acad Radiol; 1996 Aug; 3 Suppl 2():S444-6. PubMed ID: 8796625
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantification of liver capillary permeability using a macromolecular contrast agent for magnetic resonance imaging.
    Clément O; Vuillemin-Bodaghi V; Cuénod CA; Siauve N; Blustajn J; Frija G
    Acad Radiol; 1996 Aug; 3 Suppl 2():S342-3. PubMed ID: 8796598
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of extracellular contrast agents for magnetic resonance imaging.
    Weinmann HJ; Press WR; Gries H
    Invest Radiol; 1990 Sep; 25 Suppl 1():S49-50. PubMed ID: 2283256
    [No Abstract]   [Full Text] [Related]  

  • 4. MS-325: a small-molecule vascular imaging agent for magnetic resonance imaging.
    Lauffer RB; Parmelee DJ; Ouellet HS; Dolan RP; Sajiki H; Scott DM; Bernard PJ; Buchanan EM; Ong KY; Tyeklár Z; Midelfort KS; McMurry TJ; Walovitch RC
    Acad Radiol; 1996 Aug; 3 Suppl 2():S356-8. PubMed ID: 8796603
    [No Abstract]   [Full Text] [Related]  

  • 5. Urine profiles and kidney histology after ionic and nonionic radiologic and magnetic resonance contrast media in rats with cisplatin nephropathy.
    Thomsen HS; Dorph S; Larsen S; Horn T; Hemmingsen L; Skaarup P; Golman K; Svendsen O
    Acad Radiol; 1995 Aug; 2(8):675-82. PubMed ID: 9419624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat.
    Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR
    Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of contrast media for magnetic resonance imaging.
    Goldstein HA; Wiggins JR; Kashanian F
    Ann N Y Acad Sci; 1992 Mar; 649():322-31. PubMed ID: 1580503
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrast media-induced renal morphologic lesions during experimental hemorrhagic necrotizing pancreatitis.
    Tervahartiala P; Kivisaari L; Kivisaari R; Virtanen I
    Invest Radiol; 1992 Dec; 27(12):1064-8. PubMed ID: 1473926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can gadolinium be safely given in renal failure?
    Weissleder R
    AJR Am J Roentgenol; 1996 Jul; 167(1):278-9. PubMed ID: 8659405
    [No Abstract]   [Full Text] [Related]  

  • 10. Contrast media-induced renal tubular vacuolization. A light and electron microscopic study on rat kidneys.
    Tervahartiala P; Kivisaari L; Kivisaari R; Virtanen I; Standertskjöld-Nordenstam CG
    Invest Radiol; 1991 Oct; 26(10):882-7. PubMed ID: 1960030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo quantification of the blood-brain barrier injury using magnetic resonance enhancement.
    Hayakawa K; Yamashita K; Mitsumori M; Nakano Y
    Invest Radiol; 1990 Sep; 25 Suppl 1():S80-1. PubMed ID: 2283266
    [No Abstract]   [Full Text] [Related]  

  • 12. New magnetic resonance imaging contrast agents for infarct imaging based on phosphonate derivatives of Gd-DTPA.
    Adzamli IK; Blau M; Pfeffer MA; Davis MA
    Invest Radiol; 1991 Nov; 26 Suppl 1():S242-4; discussion S245-7. PubMed ID: 1808139
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurotoxic effects of gadopentetate dimeglumine: behavioral disturbance and morphology after intracerebroventricular injection in rats.
    Ray DE; Cavanagh JB; Nolan CC; Williams SC
    AJNR Am J Neuroradiol; 1996 Feb; 17(2):365-73. PubMed ID: 8938312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxicity of contrast media for magnetic resonance imaging after generalized breakdown of the blood-brain barrier.
    Evill CA; Wilson AJ; Fletcher MC; Sage MR
    Acad Radiol; 1996 Aug; 3 Suppl 2():S336-8. PubMed ID: 8796597
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats.
    McAlister WH; McAlister VI; Kissane JM
    AJNR Am J Neuroradiol; 1990; 11(2):325-7. PubMed ID: 2107714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cardiovascular changes after administration of gadodiamide injection and gadopentetate dimeglumine in dogs.
    Bøkenes J; Hustvedt SO; Refsum H
    Acad Radiol; 1997 Mar; 4(3):204-9. PubMed ID: 9084778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functional effects of gadolinium-DTPA on the isolated perfused rat kidney.
    Brown PW; Haylor JL; Morcos SK; el Nahas AM
    Eur J Radiol; 1993 Feb; 16(2):85-9. PubMed ID: 8462585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs.
    Skalpe IO; Tang GJ
    Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil.
    Yoshikawa K; Shiono T; Yamashita T; Iwai H; Abe O; Hisamatsu K; Takenaka E
    Invest Radiol; 1994 Jun; 29 Suppl 2():S245-6. PubMed ID: 7928246
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings.
    Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA
    J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.